These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9421445)

  • 21. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.
    McKee KK; Palyha OC; Feighner SD; Hreniuk DL; Tan CP; Phillips MS; Smith RG; Van der Ploeg LH; Howard AD
    Mol Endocrinol; 1997 Apr; 11(4):415-23. PubMed ID: 9092793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
    Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
    Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth Hormone (GH) but not IGF-I-Secretion is Stimulated in Aged Rats by Chronic Hexarelin and GHRP-6 administration.
    Settembrini B; Figueroa J; Gallardo M; Chiocchio S
    Endocr Regul; 1998 Mar; 32(1):17-26. PubMed ID: 10407366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoaffinity cross-linking to the pituitary receptor for growth hormone-releasing factor.
    Gaylinn BD; Lyons CE; Zysk JR; Clarke IJ; Thorner MO
    Endocrinology; 1994 Sep; 135(3):950-5. PubMed ID: 8070391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hexarelin--evaluation of factors influencing oral bioavailability and ways to improve absorption.
    Westberg C; Benkestock K; Fatouros A; Svensson M; Sjöström B
    J Pharm Pharmacol; 2001 Sep; 53(9):1257-64. PubMed ID: 11578108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment on human fetal pituitary expresses functional GHRP receptors.
    Adams E; Buchfelder M
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2216-7. PubMed ID: 9626166
    [No Abstract]   [Full Text] [Related]  

  • 28. The cardiovascular action of hexarelin.
    Mao Y; Tokudome T; Kishimoto I
    J Geriatr Cardiol; 2014 Sep; 11(3):253-8. PubMed ID: 25278975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on Neovascularization.
    Turcotte S; Mellal K; Chingle R; Mulumba M; Omri S; Dif-Yaiche L; Chemtob S; Ong H; Lubell WD
    Biomedicines; 2018 Oct; 6(4):. PubMed ID: 30360354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.
    Mousseaux D; Le Gallic L; Ryan J; Oiry C; Gagne D; Fehrentz JA; Galleyrand JC; Martinez J
    Br J Pharmacol; 2006 Jun; 148(3):350-65. PubMed ID: 16582936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study.
    Demers A; McNicoll N; Febbraio M; Servant M; Marleau S; Silverstein R; Ong H
    Biochem J; 2004 Sep; 382(Pt 2):417-24. PubMed ID: 15176951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of ghrelin secretion and action.
    Camiña JP; Carreira MC; Micic D; Pombo M; Kelestimur F; Dieguez C; Casanueva FF
    Endocrine; 2003 Oct; 22(1):5-12. PubMed ID: 14610293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic activities of growth hormone secretagogues in humans.
    Ghigo E; Arvat E; Giordano R; Broglio F; Gianotti L; Maccario M; Bisi G; Graziani A; Papotti M; Muccioli G; Deghenghi R; Camanni F
    Endocrine; 2001 Feb; 14(1):87-93. PubMed ID: 11322506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.
    Veldhuis JD; Evans WS; Bowers CY; Anderson S
    Endocrine; 2001 Feb; 14(1):45-62. PubMed ID: 11322501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system.
    Arvat E; Gianotti L; Giordano R; Broglio F; Maccario M; Lanfranco F; Muccioli G; Papotti M; Graziani A; Ghigo E; Deghenghi R
    Endocrine; 2001 Feb; 14(1):35-43. PubMed ID: 11322500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G; Locatelli V
    Endocrine; 2001 Feb; 14(1):29-33. PubMed ID: 11322499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue.
    Pan LC; Carpino PA; Lefker BA; Ragan JA; Toler SM; Pettersen JC; Nettleton DO; Ng O; Pirie CM; Chidsey-Frink K; Lu B; Nickerson DF; Tess DA; Mullins MA; MacLean DB; DaSilva-Jardine PA; Thompson DD
    Endocrine; 2001 Feb; 14(1):121-32. PubMed ID: 11322494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death.
    Filigheddu N; Fubini A; Baldanzi G; Cutrupi S; Ghè C; Catapano F; Broglio F; Bosia A; Papotti M; Muccioli G; Ghigo E; Deghenghi R; Graziani A
    Endocrine; 2001 Feb; 14(1):113-9. PubMed ID: 11322493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G
    J Endocrinol Invest; 2001 Jan; 24(1):RC1-3. PubMed ID: 11227737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.
    Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
    Pituitary; 1999 Nov; 2(3):197-204. PubMed ID: 11081154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.